Edition:
United States

Profile: DarioHealth Corp (DRIO.A)

DRIO.A on American Stock Exchange

0.40USD
20 Jun 2019
Change (% chg)

-- (--)
Prev Close
$0.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,286
52-wk High
$1.31
52-wk Low
$0.48

DarioHealth Corp, formerly Labstyle Innovations Corp, incorporated on August 11, 2011, is a digital health (mHealth) company. The Company is engaged in developing and commercializing a technology providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. The Company's product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with a pocket-sized, blood glucose monitoring device, Dario Smart Meter.

The Company's Dario product is a digital diabetes management solution utilizing its technology delivered through a software application available for iPhone or Android and cloud-based data services with a blood glucose monitoring system (BGMS) device (the Dario Smart Meter). Its Dario Smart Meter connects through a device's audio jack consisting of a lancet (to obtain a blood sample), a device-specific disposable test strip cartridge and a smart mobile device-driven glucose reader adaptor. The Company's Dario Smart Diabetes Management Solution is targeted at the mHealth application market. In addition, it is also focusing on the global diabetes care devices market for diabetic BGMS. Dario allows users to record, analyze, transmit and store various data points, such as glucose level, insulin and carbohydrate intake.

The Company's technology provides a body-fluid testing apparatus for performing metered measurement of samples utilizing a lancing device to obtain a test sample (blood in the case of Dario), and an adaptor specifically designed to connect a strip devised to absorb the sample, which then produces an electric signal indicating the level of the substance tested for in the sample. Its Dario Blood Glucose Monitoring System has components, including the Dario Blood Glucose Meter, Dario Blood Glucose Test Strips, Dario Glucose Control Solutions and the Dario application. It markets the Dario Smart Diabetes Management Solution in the Netherlands and New Zealand.

The Company competes with Abbott Laboratories, Bayer Healthcare Division, Johnson & Johnson LifeScan, Roche Diagnostics and Sanofi.

Company Address

DarioHealth Corp

8 Hatokhen St.
CAESAREA     38900
P: +9723.6222929
F: +9724.7704059

Company Web Links